Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Hartmann

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
The Journal of Allergy and Clinical Immunology|April 14, 2022
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?Peter Valent, Cem Akin, Karin Hartmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2016
111 Top-Lernziele Dermatologie: Lernzielkatalog für Haut- und Geschlechtskrankheiten der Deutschen Dermatologischen GesellschaftFalk Ochsendorf, Thyra Bandholz, Steffen Emmert, et al.
Blood|March 5, 2010
The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cellsSebastian Drube, Sylvia Heink, Sabine Walter, et al.
Blood Advances|January 31, 2018
Variability of PD-L1 expression in mastocytosisEllen W Hatch, Mary Beth Geeze, Cheyenne Martin, et al.
Current Allergy and Asthma Reports|February 17, 2026
Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil ActivationPeter Valent, Karin Hartmann, Gabriele Stefanzl, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|May 10, 2021
Ludger Klimek, Karl-Christian Bergmann, Randolf Brehler, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2022
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022Michel Arock, Gregor Hoermann, Karl Sotlar, et al.
Oncotarget|September 11, 2015
TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseasesSebastian Drube, Franziska Weber, Christiane Göpfert, et al.
Haematologica|October 4, 2016
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practiceCelalettin Ustun, Michel Arock, Hanneke C Kluin-Nelemans, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 25, 2021
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptomsMatthew P Giannetti, Emily Weller, Iván Alvarez-Twose, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
The Journal of Allergy and Clinical Immunology|April 14, 2022
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?Peter Valent, Cem Akin, Karin Hartmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2016
111 Top-Lernziele Dermatologie: Lernzielkatalog für Haut- und Geschlechtskrankheiten der Deutschen Dermatologischen GesellschaftFalk Ochsendorf, Thyra Bandholz, Steffen Emmert, et al.
Blood|March 5, 2010
The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cellsSebastian Drube, Sylvia Heink, Sabine Walter, et al.
Blood Advances|January 31, 2018
Variability of PD-L1 expression in mastocytosisEllen W Hatch, Mary Beth Geeze, Cheyenne Martin, et al.
Current Allergy and Asthma Reports|February 17, 2026
Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil ActivationPeter Valent, Karin Hartmann, Gabriele Stefanzl, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|May 10, 2021
Ludger Klimek, Karl-Christian Bergmann, Randolf Brehler, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2022
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022Michel Arock, Gregor Hoermann, Karl Sotlar, et al.
Oncotarget|September 11, 2015
TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseasesSebastian Drube, Franziska Weber, Christiane Göpfert, et al.
Haematologica|October 4, 2016
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practiceCelalettin Ustun, Michel Arock, Hanneke C Kluin-Nelemans, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 25, 2021
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptomsMatthew P Giannetti, Emily Weller, Iván Alvarez-Twose, et al.
Pageof 19